HomeTRVI • NASDAQ
add
Trevi Therapeutics Inc
Previous close
$9.75
Day range
$8.01 - $9.70
Year range
$2.36 - $9.92
Market cap
1.00B USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.72M | 3.26% |
Net income | -12.30M | 0.41% |
Net profit margin | — | — |
Earnings per share | -0.09 | 25.00% |
EBITDA | -13.68M | -3.27% |
Effective tax rate | 0.17% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 203.88M | 193.38% |
Total assets | 208.34M | 182.26% |
Total liabilities | 9.85M | 28.94% |
Total equity | 198.49M | — |
Shares outstanding | 121.78M | — |
Price to book | 5.98 | — |
Return on assets | -21.76% | — |
Return on capital | -22.89% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -12.30M | 0.41% |
Cash from operations | -10.10M | -16.33% |
Cash from investing | -2.61M | -194.29% |
Cash from financing | 110.40M | 2,078.71% |
Net change in cash | 97.68M | 11,619.34% |
Free cash flow | -5.77M | -32.05% |
About
Founded
2011
Headquarters
Website
Employees
33
